The tumour-suppressor protein ASPP1 is nuclear in human germ cells and can modulate ratios of CD44 exon V5 spliced isoforms in vivo.

The tumour-suppressor protein ASPP1 is nuclear in human germ cells and can modulate ratios of CD44 exon V5 spliced isoforms in vivo.

The ASPP1 (Apoptosis Stimulating Protein of p53) protein is an important tumour-suppressor. We have detected a novel protein interaction between the human ASPP1 (hASPP1) protein and the predominantly nuclear adaptor protein SAM68. In the human testis, full-length endogenous hASPP1 protein is located...

Bibliografske podrobnosti
Main Authors:	Thornton, J, Dalgleish, C, Venables, J, Sergeant, K, Ehrmann, I, Lu, X, Saunders, P, Elliott, D
Format:	Journal article
Jezik:	English
Izdano:	2006

Podobne knjige/članki

ASPP: a new family of oncogenes and tumour suppressor genes.
od: Sullivan, A, et al.
Izdano: (2007)

The tumour suppressor ASPP2 plays a novel role in the maintenance of epithelial cell polarity
od: Sottocornola, R
Izdano: (2010)

Regulation of CD44 binding to hyaluronan by glycosylation of variably spliced exons.
od: Bennett, K, et al.
Izdano: (1995)

Structural basis for ASPP2 recognition by the tumor suppressor p73
od: Canning, P, et al.
Izdano: (2012)

Structural basis for ASPP2 recognition by the tumor suppressor p73.
od: Canning, P, et al.
Izdano: (2012)

CD44 isoform expression mediated by alternative splicing: tissue-specific regulation in mice.
od: Hirano, H, et al.
Izdano: (1994)

CD44 isoforms containing exon V3 are responsible for the presentation of heparin-binding growth factor.
od: Bennett, K, et al.
Izdano: (1995)

ASPP2 is a haploinsufficient tumor suppressor that cooperates with p53 to suppress tumor growth.
od: Vives, V, et al.
Izdano: (2006)

Proteoglycan forms of the lymphocyte homing receptor CD44 are alternatively spliced variants containing the v3 exon.
od: Jackson, D, et al.
Izdano: (1995)

A putative exonic splicing enhancer in exon 7 of the PDHA1 gene affects splicing of adjacent exons.
od: Ridout, C, et al.
Izdano: (2008)

The N-terminus of a novel isoform of human iASPP is required for its cytoplasmic localization
od: Slee, EA, et al.
Izdano: (2004)

Alternative splicing of Apoptosis Stimulating Protein of TP53-2 (ASPP2) results in an oncogenic isoform promoting migration and therapy resistance in soft tissue sarcoma (STS)
od: Vasileia Tsintari, et al.
Izdano: (2022-07-01)

A multi-exon-skipping detection assay reveals surprising diversity of splice isoforms of spinal muscular atrophy genes.
od: Natalia N Singh, et al.
Izdano: (2012-01-01)

p53 inhibitor iASPP is an unexpected suppressor of KRAS and inflammation-driven pancreatic cancer
od: Miller, P, et al.
Izdano: (2023)

Structure of the Helicobacter pylori CagA oncoprotein bound to the human tumor suppressor ASPP2.
od: Nešić, D, et al.
Izdano: (2014)

Investigating the role of iASPP and ASPP2 in human carcinoma
od: Salter, V
Izdano: (2014)

Effect of exonic splicing regulation on synonymous codon usage in alternatively spliced exons of <it>Dscam</it>
od: Takahashi Aya
Izdano: (2009-08-01)

The Landscapes of Full-Length Transcripts and Splice Isoforms as Well as Transposons Exonization in the Lepidopteran Model System, Bombyx mori
od: Zongrui Dai, et al.
Izdano: (2021-09-01)

Universal alternative splicing of noncoding exons
od: Deveson, I, et al.
Izdano: (2018)

The Lats2 tumor suppressor augments p53-mediated apoptosis by promoting the nuclear proapoptotic function of ASPP1.
od: Aylon, Y, et al.
Izdano: (2010)

Identification and Characterization of CD44RC, a Novel Alternatively Spliced Soluble CD44 Isoform that can Potentiate the Hyaluronan Binding Activity of Cell Surface CD44
od: Roland K. Chiu, et al.
Izdano: (1999-11-01)

Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons.
od: Screaton, G, et al.
Izdano: (1992)

Merlin Isoforms 1 and 2 Both Act as Tumour Suppressors and Are Required for Optimal Sperm Maturation.
od: Ansgar Zoch, et al.
Izdano: (2015-01-01)

Predicting mutually exclusive spliced exons based on exon length, splice site and reading frame conservation, and exon sequence homology
od: Hammesfahr Björn, et al.
Izdano: (2011-06-01)

Alternative splicing in the DBD linker region of p63 modulates binding to DNA and iASPP in vitro
od: Lotz, R, et al.
Izdano: (2025)

ASPP [corrected] and cancer.
od: Trigiante, G, et al.
Izdano: (2006)

The epithelial splicing regulator ESRP2 is epigenetically repressed by DNA hypermethylation in Wilms tumour and acts as a tumour suppressor
od: Danny Legge, et al.
Izdano: (2022-02-01)

The germ cell nuclear proteins hnRNP G-T and RBMY activate a testis-specific exon.
od: Yilei Liu, et al.
Izdano: (2009-11-01)

ASPP1 and ASPP2: common activators of p53 family members.
od: Bergamaschi, D, et al.
Izdano: (2004)

ASPP1 and ASPP2 are new transcriptional targets of E2F.
od: Fogal, V, et al.
Izdano: (2005)

A splicing isoform of TEAD4 attenuates the Hippo–YAP signalling to inhibit tumour proliferation
od: Yangfan Qi, et al.
Izdano: (2016-06-01)

TDP43 promotes stemness of breast cancer stem cells through CD44 variant splicing isoforms
od: Lu Guo, et al.
Izdano: (2022-05-01)

ING Tumour Suppressors and ING Splice Variants as Coregulators of the Androgen Receptor Signalling in Prostate Cancer
od: Anna Melekhova, et al.
Izdano: (2021-09-01)

Alternative splicing in the DBD linker region of p63 modulates binding to DNA and iASPP in vitro
od: Rebecca Lotz, et al.
Izdano: (2025-01-01)

Alternative splicing of a single exon causes a major impact on the affinity of Caenorhabditis elegans tropomyosin isoforms for actin filaments
od: Shoichiro Ono, et al.
Izdano: (2023-09-01)

Identification of evolutionarily conserved exons as regulated targets for the splicing activator tra2β in development.
od: Sushma Grellscheid, et al.
Izdano: (2011-12-01)

Altered VEGF Splicing Isoform Balance in Tumor Endothelium Involves Activation of Splicing Factors Srpk1 and Srsf1 by the Wilms’ Tumor Suppressor Wt1
od: Kay-Dietrich Wagner, et al.
Izdano: (2019-01-01)

Tumour suppressors in liver carcinogenesis.
od: Dufour, J, et al.
Izdano: (2007)

Specificity of 6th Workshop CD44 panel antibodies for alternatively spliced exons and their effects on lymphocyte activation and hyaluronan binding.
od: Bannerji, S, et al.
Izdano: (1996)

Efficient exon skipping by base-editor-mediated abrogation of exonic splicing enhancers
od: Han Qiu, et al.
Izdano: (2023-11-01)